Access cutting-edge t-cell leukemia treatment through this clinical trial at a research site in Tulsa. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tulsa location
Access t-cell leukemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related t-cell leukemia treatment provided free
Check if you qualify for this t-cell leukemia clinical trial in Tulsa, OK
No-Cost Study Care
Local to Tulsa
Convenient for OK residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a clinical trial testing whether the addition of one of two chemotherapy agents, dasatinib or venetoclax, can improve outcomes for children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma or mixed phenotype acute leukemia. Primary Objective * To evaluate if the end of induction MRD-negative rate is higher in patients with T-ALL treated with dasatinib compared to similar patients treated with 4-drug induction on AALL1231. * To evaluate if the end o
Sponsor: St. Jude Children's Research Hospital
Yes, this clinical trial (NCT06390319) has an active research site in Tulsa, OK that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for t-cell leukemia treatment options in Tulsa, OK, this clinical trial (NCT06390319) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tulsa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced t-cell leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all t-cell leukemia clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Tulsa — not just this study.
Browse Leukemia Trials in Tulsa →